| Target Price | $57.12 |
| Price | $22.52 |
| Potential |
153.64%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Aeglea BioTherapeutics Inc 2026 .
The average Aeglea BioTherapeutics Inc target price is $57.12.
This is
153.64%
register free of charge
$74.55
231.04%
register free of charge
$21.21
5.82%
register free of charge
|
|
| A rating was issued by 19 analysts: 17 Analysts recommend Aeglea BioTherapeutics Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Aeglea BioTherapeutics Inc stock has an average upside potential 2026 of
153.64%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Sep 26 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Jones Trading |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Oct 25 2024 |
| Wedbush |
Locked
➜
Locked
|
Locked | Sep 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Sep 26 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 16 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Jones Trading:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Oct 25 2024 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Sep 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


